Comera Life Sciences Designates Dorothy Clarke to Board of Directors
By Karen E. Roman
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a company which develops biologic medicines, announced it has appointed Dorothy Clarke to its board of directors.
Ms. Clarke previously held leadership roles at Johnson & Johnson for over two decades and specialized in law, regulatory affairs, compliance, and data protection, the company said. She also worked as an attorney representing pharmaceutical companies and healthcare organizations, the company stated.
“Dorothy’s extensive experience will help Comera continue to deliver on its mission of delivering transformative solutions that have the potential to revolutionize the way we administer essential medicines,” said Jeffrey Hackman, Comera’s Chairman and CEO.
Contact:
Editor@Executives-edge.com
